Both Parties' Motions Shot Down In Ethyol Patent Suit
In MedImmune Oncology Inc.'s protracted patent spat against Sun Pharmaceutical Industries Ltd. over the cancer therapy drug Ethyol, a federal judge has denied MedImmune's motion for partial summary judgment as to...To view the full article, register now.
Already a subscriber? Click here to view full article